Oncology Institute insider buys 38,500 TOI shares

Oncology Institute, Inc. major shareholder Jorey Chernett reported open‑market purchases of the company’s Common Stock.

Rhea-AI Filing Summary

Oncology Institute, Inc. major shareholder Jorey Chernett reported open‑market purchases of the company’s Common Stock. He bought 5,000 shares on May 19, 2026 at $4.05 per share and 33,500 shares on May 20, 2026 at a weighted average price of $4.07 per share.

Following these transactions, Chernett directly owns 10,567,858 shares of Oncology Institute Common Stock, reflecting additional accumulation by a ten percent owner.

Insider Trade Summary

Net Buyer: 38,500 shares

Net Buy 2 txns

Insider Chernett Jorey

Role 10% Owner

Bought 38,500 shs ($157K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	33,500	$4.07	$136K
Purchase	Common Stock	5,000	$4.05	$20K

Holdings After Transaction: Common Stock — 10,567,858 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $4.05 to $4.10, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

Key Figures

Total shares purchased: 38,500 shares Purchase price May 20: $4.07 per share Purchase price May 19: $4.05 per share +1 more

4 metrics

Total shares purchased 38,500 shares Open-market Common Stock buys on May 19–20, 2026

Purchase price May 20 $4.07 per share Weighted average price for 33,500-share buy on May 20, 2026

Purchase price May 19 $4.05 per share Price for 5,000-share buy on May 19, 2026

Shares owned after trades 10,567,858 shares Direct TOI Common Stock holdings after May 20, 2026

Key Terms

open-market purchase, weighted average price, ten percent owner

3 terms

open-market purchase financial

"transaction_action: "open-market purchase" for each Common Stock transaction"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported ... is a weighted average price, rounded to the nearest cent."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

ten percent owner financial

""is_ten_percent_owner": 1 indicating Chernett is a ten percent owner"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Jorey Chernett report in his Form 4 for TOI?

Jorey Chernett reported buying Oncology Institute (TOI) Common Stock in the open market. He purchased 38,500 shares across two days in May 2026, modestly increasing his already large direct ownership stake in the company.

How many Oncology Institute (TOI) shares did Chernett purchase and at what prices?

Chernett bought a total of 38,500 Oncology Institute (TOI) shares. He acquired 5,000 shares at $4.05 per share and 33,500 shares at a weighted average price of $4.07 per share, based on multiple trades within a narrow price range.

What is Jorey Chernett’s total TOI shareholding after these transactions?

After these purchases, Chernett directly holds 10,567,858 Oncology Institute (TOI) Common Stock shares. This figure reflects his position immediately following the May 20, 2026 transactions, as reported in the Form 4 insider filing.

On which dates were the TOI shares purchased by Jorey Chernett?

Chernett’s Oncology Institute (TOI) share purchases occurred on May 19, 2026 and May 20, 2026. The Form 4 specifies separate open‑market transactions on each date, with different but closely grouped per‑share purchase prices.

What does the Form 4 say about the weighted average price for Chernett’s TOI trade?

The Form 4 notes that the $4.07 per share figure is a weighted average price. Shares were purchased in multiple transactions between $4.05 and $4.10, and Chernett undertakes to provide detailed trade prices upon request to relevant parties.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 09:35 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oncology Institute, Inc. [ TOI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		P		5,000	A	$4.05	10,534,358	D
Common Stock	05/20/2026		P		33,500	A	$4.07(1)	10,567,858	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $4.05 to $4.10, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

	/s/ Jorey Chernett	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)